Clinical Trials: Epidermolysis Bullosa

Alabama

Birmingham; UAB Department of Dermatology
Study of the Safety and Efficacy of Thymosin Beta 4 in the Treatment of Patients with Epidermolysis Bullosa (EB)

California

San Diego; Pediatric & Adolescent Dermatology, Rady Children's Hospital and Health Center
Study of the Safety and Efficacy of Thymosin Beta 4 in the Treatment of Patients with Epidermolysis Bullosa (EB)

Stanford; Vanderbilt University Medical Center Department of Dermatology
Study of the Safety and Efficacy of Thymosin Beta 4 in the Treatment of Patients with Epidermolysis Bullosa (EB)

Florida

Miami; University of Miami - School of Medicine, Department of Dermatology
Study of the Safety and Efficacy of Thymosin Beta 4 in the Treatment of Patients with Epidermolysis Bullosa (EB)

Illinois

Chicago; Research Center
Study of the Safety and Efficacy of Thymosin Beta 4 in the Treatment of Patients with Epidermolysis Bullosa (EB)

Massachusetts

Worcester; Umass Medical School
Study of the Safety and Efficacy of Thymosin Beta 4 in the Treatment of Patients with Epidermolysis Bullosa (EB)

Michigan

Detroit; Henry Ford Medical Center- New Center One Department of Dermatology
Study of the Safety and Efficacy of Thymosin Beta 4 in the Treatment of Patients with Epidermolysis Bullosa (EB)

Missouri

Columbia; University of Missouri - Columbia
Study of the Safety and Efficacy of Thymosin Beta 4 in the Treatment of Patients with Epidermolysis Bullosa (EB)

St. Louis ; Washington University, Dermatology Clinical Trials Unit
Study of the Safety and Efficacy of Thymosin Beta 4 in the Treatment of Patients with Epidermolysis Bullosa (EB)

New York

New York; Columbia University Medical Center
Study of the Safety and Efficacy of Thymosin Beta 4 in the Treatment of Patients with Epidermolysis Bullosa (EB)

Rochester; U of Rochester
Study of the Safety and Efficacy of Thymosin Beta 4 in the Treatment of Patients with Epidermolysis Bullosa (EB)

Pennsylvania

Erie; St. Vincent's Hospital
Study of the Safety and Efficacy of Thymosin Beta 4 in the Treatment of Patients with Epidermolysis Bullosa (EB)

Tennessee

Nashville; Vanderbilt University Medical Center Department of Dermatology
Study of the Safety and Efficacy of Thymosin Beta 4 in the Treatment of Patients with Epidermolysis Bullosa (EB)

Virginia

Norfolk; Virginia Clinical Research, Inc.
Study of the Safety and Efficacy of Thymosin Beta 4 in the Treatment of Patients with Epidermolysis Bullosa (EB)


Back to Clinical Trials by Medical Areas

Research centers
specializing in
this illness area

Additional resources
in this illness area

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listing updated: May 13, 2008 at 3:01:02 PM

Copyright © 1995 - 2008, CenterWatch
All Rights Reserved

This site was developed in association with Illumina Interactive, Boston, MA